Publisher: Elsevier

Related content
Volume 8, Number 5, March 2003

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Don't shoot the messenger
pp. 187-188(2)
Author: Whelan, J.

Favourites:Add to Favourites

Gleevec: tailoring to fit
pp. 188-189(2)
Author: May, T.S.

Favourites:Add to Favourites

Smart bombs: the next generation of PDT
pp. 190-191(2)
Author: Thacker, P.D.

Favourites:Add to Favourites

News in brief
pp. 191-194(4)
Authors: Brown, M.; Carey, J.; Chan, P.; Clough, J.; Rathbone, C.; Robertson, M.; Viccars, C.; Wild, C.; Whisker, B.; Yeomans, H.

Favourites:Add to Favourites

People
pp. 195-195(1)
Author: Clough, J.

Favourites:Add to Favourites

Drug discovery perspective of chemical-driven mouse mutagenesis?
pp. 199-199(1)
Authors: Xie, W.; Uppal, H.

Favourites:Add to Favourites

ENU mutagenesis for pharma
pp. 199-200(2)
Author: Adams, M.D.

Favourites:Add to Favourites
Favourites:Add to Favourites

Delivering the power of discovery in large pharmaceutical organizations
pp. 203-211(9)
Authors: Peakman, T.; Franks, S.; White, C.; Beggs, M.

Favourites:Add to Favourites

Rational design and engineering of therapeutic proteins
pp. 212-221(10)
Authors: Marshall, S.A.; Lazar, G.A.; Chirino, A.J.; Desjarlais, J.R.

Favourites:Add to Favourites
Favourites:Add to Favourites

Novel antitumour molecules
pp. 229-231(3)
Author: Westwell, A.D.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more